Cargando…
Identification of a novel target of SETD1A histone methyltransferase and the clinical significance in pancreatic cancer
Although histone H3K4 methyltransferase SETD1A is overexpressed in various cancer types, the molecular mechanism underlying its overexpression and its target genes in pancreatic ductal adenocarcinoma (PDAC) remain unclarified. We conducted immunohistochemical staining for SETD1A in 105 human PDAC sp...
Autores principales: | Ishii, Takeshi, Akiyama, Yoshimitsu, Shimada, Shu, Kabashima, Ayano, Asano, Daisuke, Watanabe, Shuichi, Ishikawa, Yoshiya, Ueda, Hiroki, Akahoshi, Keiichi, Ogawa, Kosuke, Ono, Hiroaki, Kudo, Atsushi, Tanabe, Minoru, Tanaka, Shinji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899616/ https://www.ncbi.nlm.nih.gov/pubmed/36271761 http://dx.doi.org/10.1111/cas.15615 |
Ejemplares similares
-
RRM1 is mediated by histone acetylation through gemcitabine resistance and contributes to invasiveness and ECM remodeling in pancreatic cancer
por: Ono, Hiroaki, et al.
Publicado: (2023) -
Loss of SFXN1 mitigates lipotoxicity and predicts poor outcome in non-viral hepatocellular carcinoma
por: Yagi, Kohei, et al.
Publicado: (2023) -
Pancreatic metastasis from renal cell carcinoma presenting as gastrointestinal hemorrhage: a case report
por: Matsui, Satoshi, et al.
Publicado: (2021) -
Intrinsic activation of β-catenin signaling by CRISPR/Cas9-mediated exon skipping contributes to immune evasion in hepatocellular carcinoma
por: Akasu, Masafumi, et al.
Publicado: (2021) -
Surgery after sunitinib administration to improve survival of patients with advanced pancreatic neuroendocrine neoplasms
por: Murase, Yoshiki, et al.
Publicado: (2021)